Meet our team

Ann is Acting CEO at Droplet Biosciences and a General Partner at Engine Ventures. Previously, she held senior roles in business development and venture investment at Sanofi, and before that, worked at Flagship Pioneering. Ann holds a PhD from MIT and an MBA from Harvard. She serves on the board of Nucleate, Harvard's Blavatnik Life Science Entrepreneurship Council, and Prime Coalition's Investment Advisory Committee.

Wendy Winckler has over 20 years of genomics experience, including serving as CSO for Glympse Bio. She led Oncology Next Generation Diagnostics at Novartis and numerous early cancer genome studies at the Broad Institute. Dr. Winckler holds a BS in microbiology and molecular genetics from UCLA and a PhD in genetics from Harvard.

Dr. Haluk Tezcan is the Chief Medical Officer at Droplet Biosciences, with over 30 years of experience in oncology, hematology, clinical research, and executive leadership. A board-certified medical oncologist and hematologist, he has focused his career on advancing cancer diagnostics and personalized medicine. Before joining Droplet, he was VP of Clinical Development at Foundation Medicine, leading efforts in molecular diagnostics and precision oncology. He also served as CMO at Lexent Bio, where he guided the development of its liquid biopsy platform, leading to its acquisition by Roche/Foundation Medicine. Dr. Tezcan has also held senior roles at N-Power Medicine, Counsyl, and Genomic Health. He currently serves on the faculty in Breast Medical Oncology at Stanford University School of Medicine.

Stephen Miller has over 30 years of commercial and reimbursement experience in diagnostics, including serving as VP of Sales & Marketing for Athena Diagnostics (a Thermo Fisher company). He has launched over 200 diagnostic products in his career and most recently was Chief Commercial Officer at Biofidelity, a UK-based precision medicine company. Mr. Miller received his undergraduate degree from Miami University.

Jose P. Zevallos is Chair of Otolaryngology at UPMC. He previously served as Division Chief and Professor of Head & Neck Surgical Oncology at Washington University in St. Louis. He has published over 120 peer-reviewed articles and is a frequent speaker at conferences in his field. Dr. Zevallos earned a Biology degree from Middlebury and a medical degree from Rutgers.

Aadel Chaudhuri is Assistant Professor of Radiation Oncology and leads the Chaudhuri Lab at Washington University in St. Louis, where his clinical practice focuses on lung cancer. He is highly published in the ctDNA field. Dr. Chaudhuri completed his undergraduate studies at MIT, his PhD at CalTech, and his medical degree at Stanford.

Stan Lapidus serves on the board of directors at Droplet. He founded Cytyc Corp, which revolutionized cervical cancer screening through the ThinPrep pap test, and Exact Sciences, which did the same for colon cancer screening. Stan holds 37 patents and is a fellow of the American Institute of Medical and Biological Engineering.

Theresa Tribble has spent the past 20 years building early-stage life science companies. She served as Chief Business Officer of Everlywell, the leader in at-home testing and helped found BigHat Biosciences and Landsdowne Labs. Theresa earned her undergraduate degree at Wellesley College and her MBA at Harvard Business School.